Despite the elevated levels of D-dimer and inflammatory markers in circulation, the thrombophilia screening revealed that she carried a heterozygous prothrombin 20210A allele, which contributes to her vulnerability to thrombotic events. This evidence concerns the gene F2 and thrombophilia.